COLUMBUS, Ohio – A study led by researchers at the Ohio State University Comprehensive Cancer Center and Dana-Farber Cancer Institute reveals how late-stage, hormone-independent prostate tumors gain the ...
The rest of the story
COLUMBUS, Ohio – The drug tamoxifen is widely used to treat breast cancer patients, but 30 percent of people do not respond or become resistant to it.
A study by researchers at The Ohio State University ...
The rest of the story
